What: Challenges and Promise of Cell-Based Therapies is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. This will be followed by four plenary sessions that will highlight cell-based therapies for the treatment of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders. It will close with a presentation on induced pluripotent stem cells (iPSCs) and the issues that need to be addressed to enable their potential use in cell-based therapies.
Why: The purpose of the symposium is to determine productive new directions for research in regenerative medicine and to help NIH prioritize research with the greatest potential for clinical benefit.
Who: Speakers include:
Story C. Landis, Ph.D., National Institute of Neurological Disorders and Stroke, National Institutes of Health
James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, National Institutes of Health
Paolo Bianco, M.D., Sapienza Universita' di Roma
George Daley, M.D., Ph.D., Harvard Stem Cell Institute
Mark S. Freedman, M.D., M.Sc., University of Ottawa
Linda Griffith, Ph.D., Massachusetts Institute of Technology
Markus Grompe, M.D., Oregon Health & Science University
Douglas Kerr, M.D., Ph.D., Johns Hopkins University
Michael A. Laflamme, M.D., Ph.D., University of Washington
Annarosa Leri, M.D., Harvard Medical School
Douglas W. Losordo, M.D., Northwestern University
Stuart H. Orkin, M.D., Harvard Stem Cell Institute
Terence A. Partridge, Ph.D., Childrens National Medical Center
Darwin Prockop, M.D., Ph.D., Tulane University Medical School
Clive N. Svendsen, Ph.D., University of Wisconsin-Madison
Kenneth Zaret, Ph.D., Fox Chase Cancer Center
When: Tuesday, May 6, 2008, 8 a.m. to 5: 30
'/>"/>
| Contact: Marian Emr 301-496-5924 NIH/National Institute of Neurological Disorders and Stroke Source:Eurekalert |